Results 221 to 230 of about 683,865 (337)
Machine learning-based model for predicting all-cause mortality in severe pneumonia. [PDF]
Zhao W+10 more
europepmc +1 more source
The antibacterial double‐layered wound dressing is fabricated using chitosan (CH) film as the contact layer and tigecycline (Tig)‐loaded poly(ε‐caprolactone) (PCL) nanofibers as the top layer. The CH film has a uniform morphology, and the PCL‐Tig nanofibers show a smooth, randomly oriented, and beadless structure.
Ş. Melda Eskitoros‐Togay+5 more
wiley +1 more source
Outcome and management of children with chest indrawing pneumonia at primary health care settings in Pakistan: an observational cohort study. [PDF]
Suhag ZH+8 more
europepmc +1 more source
Objective An unmet need exists for glucocorticoid‐sparing treatments for patients with polymyalgia rheumatica (PMR). The antibody‐drug conjugate ABBV‐154 comprises adalimumab conjugated to a glucocorticoid receptor modulator. We evaluated ABBV‐154 versus placebo in patients with glucocorticoid‐dependent PMR.
Robert F. Spiera+14 more
wiley +1 more source
Computed tomography-based radiomic features combined with clinical parameters for predicting post-infectious bronchiolitis obliterans in children with adenovirus pneumonia: a retrospective study. [PDF]
Zhang L+10 more
europepmc +1 more source
TYPES OF PNEUMOCOCCUS FOUND IN THE PNEUMONIAS OF INFANTS AND YOUNG CHILDREN [PDF]
Martha Wollstein
openalex +1 more source
Long‐Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis
Objectives Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, relapsing, inflammatory disease. Management of EGPA predominantly relies on oral corticosteroids (OCS), which are associated with many adverse effects. The Phase III MIRRA trial demonstrated efficacy and safety of mepolizumab, anti‐interleukin‐5 biologic, for EGPA.
Michael E Wechsler+34 more
wiley +1 more source
MIP-3-Alpha and MIP-3-Beta as Early Predictors of Pneumonia in Polytraumatized Patients. [PDF]
Wollner G+5 more
europepmc +1 more source